Formula Pharmaceuticals Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

  • Investments
  • 1

Formula Pharmaceuticals General Information

Description

Developer of chimeric antigen receptor immunotherapies designed for critical unmet medical needs in cancer. The company offers leverages an allogeneic source, non-viral transfection and a differentiated immune effector cell, called cytokine-induced killer cells for developing cancer immunotherapies.

Contact Information

Formerly Known As
Formula Pharmaceuticals, Inc.
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Corporate Office
  • 1055 Westlakes Drive
  • Suite 300
  • Berwyn, PA 19312
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Parent Company
Vertical(s)
Corporate Office
  • 1055 Westlakes Drive
  • Suite 300
  • Berwyn, PA 19312
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Formula Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Formula Pharmaceuticals‘s full profile, request access.

Request a free trial

Formula Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of chimeric antigen receptor immunotherapies designed for critical unmet medical needs in cancer. The company
Biotechnology
Berwyn, PA

Barcelona, Spain
 

Madison, WI
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Formula Pharmaceuticals Competitors (6)

One of Formula Pharmaceuticals’s 6 competitors is Ability Pharma, a Private Equity-Backed company based in Barcelona, Spain.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ability Pharma Private Equity-Backed Barcelona, Spain
Immuto Scientific Venture Capital-Backed Madison, WI
Bristol-Myers Squibb Corporation Princeton, NJ
Amgen Formerly PE-Backed Thousand Oaks, CA
Gilead Sciences Formerly VC-backed Foster City, CA
To view Formula Pharmaceuticals’s complete competitors history, request access »

Formula Pharmaceuticals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Formula Pharmaceuticals‘s full profile, request access.

Request a free trial

Formula Pharmaceuticals Investments (1)

Formula Pharmaceuticals’s most recent deal was a Corporate Asset Purchase with Non-Viral Chimeric Antigen Receptor (CAR) Immunotherapy Platform. The deal was made on 11-May-2015.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Non-Viral Chimeric Antigen Receptor (CAR) Immunotherapy Platform 11-May-2015 Corporate Asset Purchase Buildings and Property
To view Formula Pharmaceuticals’s complete investments history, request access »

Formula Pharmaceuticals FAQs

  • When was Formula Pharmaceuticals founded?

    Formula Pharmaceuticals was founded in 2009.

  • Where is Formula Pharmaceuticals headquartered?

    Formula Pharmaceuticals is headquartered in Berwyn, PA.

  • What industry is Formula Pharmaceuticals in?

    Formula Pharmaceuticals’s primary industry is Biotechnology.

  • Is Formula Pharmaceuticals a private or public company?

    Formula Pharmaceuticals is a Private company.

  • What is Formula Pharmaceuticals’s current revenue?

    The current revenue for Formula Pharmaceuticals is .

  • Who are Formula Pharmaceuticals’s investors?

    PIPV Capital has invested in Formula Pharmaceuticals.

  • Who are Formula Pharmaceuticals’s competitors?

    Ability Pharma, Immuto Scientific, Bristol-Myers Squibb, Amgen, and Gilead Sciences are some of the 6 competitors of Formula Pharmaceuticals.

  • When was Formula Pharmaceuticals acquired?

    Formula Pharmaceuticals was acquired on 16-Jan-2020.

  • Who acquired Formula Pharmaceuticals?

    Formula Pharmaceuticals was acquired by Argos Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »